Journal of Arthritis and RheumatologyJournal of Arthritis and RheumatologyJournal of Arthritis and RheumatologyIn the meanwhile, baricitinib is used fewer than tofacitinib. An all-circumstance PMS analyze of baricitinib analyzed its basic safety and efficacy profile in Japanese patients with RA from September 2017 to June 2020.Title your collection